Harvard Bioscience Inc (HBIO)
2.22
+0.06
(+2.78%)
USD |
NASDAQ |
Nov 22, 11:00
Harvard Bioscience Revenue (Quarterly): 21.97M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 21.97M |
| June 30, 2024 | 23.10M |
| March 31, 2024 | 24.51M |
| December 31, 2023 | 28.15M |
| September 30, 2023 | 25.36M |
| June 30, 2023 | 28.76M |
| March 31, 2023 | 29.98M |
| December 31, 2022 | 28.43M |
| September 30, 2022 | 26.92M |
| June 30, 2022 | 29.21M |
| March 31, 2022 | 28.78M |
| December 31, 2021 | 33.06M |
| September 30, 2021 | 29.66M |
| June 30, 2021 | 29.20M |
| March 31, 2021 | 26.99M |
| December 31, 2020 | 30.98M |
| September 30, 2020 | 24.04M |
| June 30, 2020 | 23.31M |
| March 31, 2020 | 23.77M |
| December 31, 2019 | 30.97M |
| September 30, 2019 | 27.42M |
| June 30, 2019 | 29.58M |
| March 31, 2019 | 28.20M |
| December 31, 2018 | 33.86M |
| September 30, 2018 | 28.64M |
| Date | Value |
|---|---|
| June 30, 2018 | 31.52M |
| March 31, 2018 | 26.76M |
| December 31, 2017 | 21.65M |
| September 30, 2017 | 18.72M |
| June 30, 2017 | 18.96M |
| March 31, 2017 | 18.09M |
| December 31, 2016 | 26.42M |
| September 30, 2016 | 25.01M |
| June 30, 2016 | 26.14M |
| March 31, 2016 | 26.96M |
| December 31, 2015 | 28.37M |
| September 30, 2015 | 25.73M |
| June 30, 2015 | 28.80M |
| March 31, 2015 | 25.76M |
| December 31, 2014 | 30.36M |
| September 30, 2014 | 25.45M |
| June 30, 2014 | 26.96M |
| March 31, 2014 | 25.89M |
| December 31, 2013 | 27.85M |
| September 30, 2013 | 25.14M |
| June 30, 2013 | 26.09M |
| March 31, 2013 | 26.09M |
| December 31, 2012 | 28.25M |
| September 30, 2012 | 26.10M |
| June 30, 2012 | 28.50M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
21.97M
Minimum
Sep 2024
33.06M
Maximum
Dec 2021
27.36M
Average
28.29M
Median
Revenue (Quarterly) Benchmarks
| Bruker Corp | 864.40M |
| Azenta Inc | 170.06M |
| Bionano Genomics Inc | 6.073M |
| Akoya Biosciences Inc | 18.81M |
| Singular Genomics Systems Inc | 0.406M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.802M |
| Total Expenses (Quarterly) | 23.66M |
| EPS Diluted (Quarterly) | -0.11 |
| Enterprise Value | 127.50M |
| Gross Profit Margin (Quarterly) | 58.10% |
| Profit Margin (Quarterly) | -21.86% |
| Earnings Yield | -14.86% |
| Normalized Earnings Yield | -12.72 |